Two domains within the adenovirus type 12 E1A unique spacer have disparate effects on the interaction of E1A with P105-Rb and the transformation of primary mouse cells

Virology

Volumn 257, Issue 1, 1999, Pages 45-53

  Rumpf, Heike ^a   Esche, Helmut ^a   Kirch, Hans Christoph ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYPARAMIDE; ONCOPROTEIN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARCINOGENICITY; CELL TRANSFORMATION; GENE EXPRESSION; GROWTH INHIBITION; HYDROPHOBICITY; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RODENT; SEROTYPE;

EID: 0033602573     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9651     Document Type: Article

References (48)

1. Bagchi S., Raychaudhuri P., Nevins J. R. Adenovirus E1A proteins can dissociate heteromeric cellular complexes involving the E2F transcription factor. Cell. 62:1990;659-669.
2. Barbeau D., Charbonneau R., Whalen S. G., Bayley S. T., Branton P. Functional interactions within adenovirus E1A complexes. Oncogene. 9:1994;359-373.
3. Berk A. G., Lee F., Harrison T., Williams J., Sharp P. Pre-early adenovirus 5 gene product regulates synthesis of early messenger RNAs. Cell. 17:1979;935-944.
4. Bondesson M., Svensson C, Linder S., Akusjarvi G. The carboxy-terminal exon of the adenovirus E1A protein is required for E4F-dependent transcription activation. EMBO J. 11:1992;3347-3354.
5. Brockmann D., Esche H. Regulation of viral and cellular gene expression by E1A proteins encoded by the oncogenic adenovirus type 12. Curr. Topics Microbiol. Immunol. 199:1995;82-112.
6. Cobrinik D., Whyte P., Peeper D. S., Jacks T., Weinberg R. A. Cell cycle specific association of E2F with the p130 E1A-binding protein. Genes Dev. 7:1993;2392-2404.
7. Dyson N., Guida P., McCall C., Harlow E. Adenovirus E1A makes two contact points with the retinoblastoma protein. J. Virol. 66:1992;4606-4611.
8. Fattaey A. R., Harlow E., Helin C. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes. Mol. Cell. Biol. 13:1993;7267-7277.
9. Ferguson B., Krippl B., Andrisani O., Jones N., Westphal H., Rosenberg M. E1A 13S and 12S mRNA-products made inEscherichia coli. Mol. Cell. Biol. 5:1985;2653-2661.
10. Gallimore P. H., Bird P. J., Grand R. J. A. Adenovirus genes involved in transformation: What determines the oncogenic phenotype. 1985;Cambridge University Press. p. 126-172.
11. Geisberg J. V., Chen J., Ricciardi R. P. The zinc finger region of the adenovirus E1A transactivation domain complexes with the TATA box binding protein. Proc. Natl. Acad. Sci. USA. 91:1994;6283-6290.
12. Grand R. J. A., Ibrahim A. P., Taylor A. M. R., Milner A. E., Gregory C. D., Gallimore P. H., Turnell A. S. Human cells arrest in S-phase in response to adenovirus 12 E1A. Virology. 244:1998;330-342.
13. Harbour J. W., Lai S. L., Whang-Peng J., Gazdar A. F., Minna J. D., Kaye F. J. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science. 241:1988;353-357.
14. Ikeda M. A., Nevins J. R. Identification of distinct roles for separate E1A domains in disruption of E2F complexes. Mol. Cell. Biol. 13:1993;7029-7035.
15. Jansen-Dürr P. How viral oncogenes make the cell cycle. Trends Genet. 12:1996;270-275.
16. Jelinek T., Pereira D. S., Graham F. Tumorigenicity of adenovirus transformed rodent cells is influenced by at least two regions of adenovirus type 12 early region 1A. J. Virol. 68:1994;888-896.
17. Jones N. Transcriptional modulation by the adenovirus E1A gene. Curr. Topics Microbiol. Immunol. 199:1995;59-79.
18. Kawamura H., Wada N., Makino Y., Tamura T. A., Koikeda S., Shiroki K., Masamune Y., Nakanishi Y. Transcription stimulation of the adenovirus type 12 E1A gene in vitro by the 266-amino-acid E1A protein. J. Virol. 68:1994;5056-5062.
19. Kirch H.-C., Flaswinkel S., Rumpf H., Brockmann D., Esche H. Expression of humanp53p53. Oncogene. 1999.
20. Kirch H.-C., Pützer B., Brockmann D., Esche H., Kloke O. Formation of the early-region-2 transcription-factor-1-retinoblastoma-proteintrans. Eur. J. Biochem. 246:1997;736-744.
21. Kirch H.-C., Pützer B., Schwabe G., Krüger H., Gnauck A., Schulte Holthausen H. Regulation of adenovirus 12 E1A transcription: E2F and ATF motifs in the E1A promotor bind nuclear protein complexes including E2F1, DP-1, cyclin A and/or p105-RB and mediate transcriptional autoactivation. Cell. Mol. Biol. Res. 39:1993;705-716.
22. Kirch H.-C., Schröder J., Hoppe H., Esche H., Seeber S., Schütte J. Recombinant gene products of two natural variants of the human cytidine deaminase gene confer different deamination rates of cytarabine in vitro. Exp. Hematol. 26:1998;421-425.
23. Kloke O., Moritz T., Kummer G., Hust H., Ross B., Seeber S., Niederle N. Opposite sensitivity to the antiproliferative action of interferon- and granulocyte-macrophage colony-stimulating factor in monoblastic U937 cells. J. Interferon Res. 12:1992;369-376.
24. LaThangue N. B., Thimmapaya B., Rigby P. W. The embryo carcinoma stem cell E1A-like activity involves a differentiation-regulated transcription factor. Nucleic Acids Res. 18:1990;2929-2938.
25. Leclére V., Huvent I., Verwaerde P., Cousin C. Comparison between E1A gene from oncogenic and nononcogenic adenoviruses. Arch. Virol. 132:1993;343-357.
26. Lee W., Kao C. C., Bryant G. O., Liu X., Berk A. J. Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor. Cell. 67:1991;365-376.
27. Licht J. D., Grossel M. J., Figge J., Hansen U. M. Drosophila. Nature. 346:1990;76-79.
28. Lipinski K. S., Kröner-Lux G., Esche H., Brockmann D. The E1A N terminus (aa 1-29) of the highly oncogenic adenovirus type 12 harbours a trans-activation function not detectable in the non oncogenic serotype 2. J. Gen. Virol. 78:1997;413-421.
29. Lynch M. J., Trainer D. L. Immortalization of primary rat kidney cells by retroviral mediated gene transfer of adenovirus E1A genes. Cancer Res. 49:1989;5429-5434.
30. MacPherson I. A., Montagnier L. Agar suspension culture for the selective assay of cells transformed by polyoma virus. Virology. 23:1964;291-294.
31. Mayol X., Garriga J., Grana X. Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. Oncogene. 11:1995;801-808.
32. Mayol X., Grana X. The p130 pocket protein: Keeping order at cell cycle exit/re-entrance transitions. Front. Biosci. 3:1998;11-24.
33. Nevins J. R. Mechanism of activation of early viral transcription by the adenovirus E1A gene product. Cell. 26:1981;213-220.
34. Nevins J. R. Adenovirus E1A: Transcription regulation and alteration of growth control. Curr. Topics Microbiol. Immunol. 199:1995;25-32.
35. Parker S. F., Felzien L. K., Perkins N. D., Imperiale M. J., Nabel G. J. Distinct domains of adenovirus E1A interact with specific cellular factors to differentially modulate human immunodeficiency virus transcription. J. Virol. 71:1997;2004-2012.
36. Pützer B. M., Gnauk J., Kirch H.-C., Brockmann D., Esche H. Acis. J. Gen. Virol. 78:1997;413-421.
37. Ruley H. E. Adenovirus region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature. 304:1983;602-606.
38. Shenk T., Flint S. J. Transcriptional and transforming activities of the adenovirus E1A proteins. Adv. Cancer Res. 57:1991;47-83.
39. Slansky J., Li Y., Kaelin W. G., Farnham P. J. A protein synthesis dependent increase in E2F-1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol. Cell. Biol. 13:1993;1610-1618.
40. Smith E. J. Leone G., Nevins J. R. Distinct mechanisms control the accumulation of the p105-Rb-related p107 and p130 proteins during cell growth. Cell Growth Differ. 9:1998;297-303.
41. Strom A. C., Ohlsson P., Akusjarvi G. AR1 is an integral part of the adenovirus type 2 E1A-CR3 transactivation domain. J. Virol. 72:1998;5978-5983.
42. Telling G. C., Williams J. Constructing chimeric type 12/type 5 adenovirus E1A genes and using them to identify an oncogenic determinant of adenovirus type 12. J. Virol. 68:1994;877-887.
43. Wang H. H., Rikitake Y., Cater C., Yaciuk P., Abraham S. E., Zerler B., Moran E. Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J. Virol. 67:1993;476-488.
44. Weintraub S. J., Prater C. A., Dean D. C. Retinoblastoma protein switches the E2F site from a positive to a negative element. Nature. 358:1992;259-261.
45. White E. Regulation of p53-dependent apoptosis by E1A and E1B. Curr. Topics Microbiol. Immunol. 199:1995;33-57.
46. Whyte P., Williams N. M., Harlow E. Cellular targets for the transformation by the adenovirus E1A proteins. Cell. 56:1989;67-75.
47. Williams J., Williams M., Liu C., Telling G. Assessing the role of E1A in the differential oncogenicity of group A and group C human adenoviruses. Curr. Topics Microbiol. Immunol. 199:1995;149-175.
48. Zantema A., van der Eb A. J. Modulation of gene expression by adenovirus transformation. Curr. Topics Microbiol. Immunol. 199:1995;3-21.